AVTX: Avalo Therapeutics, Inc. Common Stock Company Profile & Statistics

Avalo Therapeutics, Inc. Common Stock Profile

About

Avalo Therapeutics Inc. is a clinical-stage precision medicine company which discovers, develops and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology and rare genetic diseases. Avalo Therapeutics Inc., formerly known as Cerecor, is based in WAYNE, Pa.

Info & Links

CEO

Garry Neil

Headquarters

540 Gaither Road, Suite 400
Rockville, MD 20850, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

149

Employees

Avalo Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

189M

Enterprise Value

146.69M

Enterprise Value/EBITDA(ttm)

-2.45

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

1.39

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

110.62%

Operating Margin(ttm)

Profit Margin(ttm)

-2288.48%

Return on Equity(ttm)

-48.48%

Return on Invested Capital(ttm)

44.19%

Return on Assets(ttm)

-35.94%

Income Statement

Revenue(ttm)

441.00K

Revenue Per Share(ttm)

0.03

Gross Profit(ttm)

1.07M

EBITDA(ttm)³

-59.78M

Net Income Available to Common(ttm)

-46.22M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

0.93

52-Week Change

43.00%

S&P 500 52-Week Change

18.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

13.15M

Dividend Yield

0.00%

Float⁴

13.12M

% Held by Insiders

0.25%

% Held by Institutions

87.06%

Balance Sheet

Total Cash(mrq)

113.28M

Total Cash Per Share(mrq)

8.61

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

12.44%

Quick Ratio(mrq)

12.44%

Book Value Per Share(mrq)

9.65

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.93

Free Cash Flow(ytd)

-91.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

AVTX

Avalo Therapeutics, Inc. Common Stock